Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Estrogen signaling via membrane-associated receptors, specifically the G protein-coupled estrogen receptor 1 (GPER1, formerly GPR30) and membrane-localized estrogen receptor alpha (mERα), mediates the rapid, non-genomic effects of estrogen (Prossnitz & Barton, 2011, Nature Reviews Endocrinology). Unlike classical nuclear estrogen receptors that regulate gene transcription over hours, these membrane-bound proteins trigger immediate signaling cascades, including the MAPK/ERK, PI3K/Akt, and calcium signaling pathways, within seconds or}
Activation of membrane-bound GPER1 or mERα initiates rapid intracellular signaling cascades, such as Src-mediated EGFR transactivation, which subsequently activates the MAPK/ERK and PI3K/Akt pathways, leading to rapid cellular responses independent of direct gene transcription (Prossnitz & Barton, 2011, Nature Reviews Endocrinology).
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on G protein-coupled estrogen receptor 1 and membrane-associated Estrogen receptor alpha (GPER1/mERα).